Integrum Financial Statements From 2010 to 2024
| INTEG-B Stock | SEK 22.70 0.20 0.89% |
Check Integrum financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integrum's main balance sheet or income statement drivers, such as , as well as many indicators such as . Integrum financial statements analysis is a perfect complement when working with Integrum Valuation or Volatility modules.
Integrum |
Integrum AB Series Company Profit Margin Analysis
Integrum's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Integrum Profit Margin | 0.07 % |
Most of Integrum's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integrum AB Series is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Integrum AB Series has a Profit Margin of 0.0735%. This is 100.66% lower than that of the Healthcare sector and 100.41% lower than that of the Medical Instruments & Supplies industry. The profit margin for all Sweden stocks is 105.79% lower than that of the firm.
Integrum AB Series Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Integrum's current stock value. Our valuation model uses many indicators to compare Integrum value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Integrum competition to find correlations between indicators driving Integrum's intrinsic value. More Info.Integrum AB Series is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Integrum by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Integrum's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Integrum Financial Statements
Integrum stakeholders use historical fundamental indicators, such as Integrum's revenue or net income, to determine how well the company is positioned to perform in the future. Although Integrum investors may analyze each financial statement separately, they are all interrelated. For example, changes in Integrum's assets and liabilities are reflected in the revenues and expenses on Integrum's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Integrum AB Series. Please read more on our technical analysis and fundamental analysis pages.
Integrum AB researches, develops, and sells various systems for bone-anchored prostheses. The company was founded in 1962 and is based in Mlndal, Sweden. Integrum is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Integrum Stock
Integrum financial ratios help investors to determine whether Integrum Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Integrum with respect to the benefits of owning Integrum security.